Aequim Alternative Investments’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-50,000
Closed -$113K 95
2020
Q3
$113K Buy
+50,000
New +$113K 0.02% 71